10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
MERCK & CO., INC. | |||
Ticker: MRK Fiscal Year: 2018 | |||
Consolidated Statement of Income | |||
Period Ending Dec 31, 2018 10-K (Filed: Feb 27, 2019) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | |
| Sales | $ 42,294 | 40,122 | 39,807 |
| Costs, Expenses and Other | |||
| Cost of sales | 13,509 | 12,912 | 14,030 |
| Selling, general and administrative | 10,102 | 10,074 | 10,017 |
| Research and development | 9,752 | 10,339 | 10,261 |
| Restructuring costs | 632 | 776 | 651 |
| Other (income) expense, net | (402) | (500) | 189 |
| Total Costs, Expenses and Other | 33,593 | 33,601 | 35,148 |
| Income Before Taxes | 8,701 | 6,521 | 4,659 |
| Taxes on Income | 2,508 | 4,103 | 718 |
| Net Income | 6,193 | 2,418 | 3,941 |
| Less: Net (Loss) Income Attributable to Noncontrolling Interests | (27) | 24 | 21 |
| Net Income Attributable to Merck & Co., Inc. | 6,220 | 2,394 | 3,920 |
| Basic Earnings per Common Share Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share) | 2.34 | 0.88 | 1.42 |
| Earnings per Common Share Assuming Dilution Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share) | 2.32 | 0.87 | 1.41 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
MERCK & CO., INC. | |||
Ticker: MRK Fiscal Year: 2018 | |||
Consolidated Statement of Comprehensive Income | |||
Period Ending Dec 31, 2018 10-K (Filed: Feb 27, 2019) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | |
| Net Income Attributable to Merck & Co., Inc. | $ 6,220 | 2,394 | 3,920 |
| Other Comprehensive (Loss) Income Net of Taxes: | |||
| Net unrealized gain (loss) on derivatives, net of reclassifications | 297 | (446) | (66) |
| Net unrealized loss on investments, net of reclassifications | (10) | (58) | (44) |
| Benefit plan net (loss) gain and prior service (cost) credit, net of amortization | (425) | 419 | (799) |
| Cumulative translation adjustment | (223) | 401 | (169) |
| Other comprehensive income (loss), net of taxes | (361) | 316 | (1,078) |
| Comprehensive Income Attributable to Merck & Co., Inc. | 5,859 | 2,710 | 2,842 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
MERCK & CO., INC. | |||
Ticker: MRK Fiscal Year: 2018 | |||
Consolidated Statement of Cash Flows | |||
Period Ending Dec 31, 2018 10-K (Filed: Feb 27, 2019) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | |
| Cash Flows from Operating Activities | |||
| Net income | $ 6,193 | 2,418 | 3,941 |
| Adjustments to reconcile net income to net cash provided by operating activities: | |||
| Depreciation and amortization | 4,519 | 4,676 | 5,471 |
| Intangible asset impairment charges | 296 | 646 | 3,948 |
| Charge for future payments related to collaboration license options | 650 | 500 | 0 |
| Provisional charge for one-time transition tax related to the enactment of U.S. tax legislation | 0 | 5,347 | 0 |
| Charge related to the settlement of worldwide Keytruda patent litigation | 0 | 0 | 625 |
| Deferred income taxes | (509) | (2,621) | (1,521) |
| Share-based compensation | 348 | 312 | 300 |
| Other | 978 | 190 | 213 |
| Net changes in assets and liabilities: | |||
| Accounts receivable | (418) | 297 | (619) |
| Inventories | (911) | (145) | 206 |
| Trade accounts payable | 230 | 254 | 278 |
| Accrued and other current liabilities | (341) | (922) | (2,018) |
| Income taxes payable | 827 | (3,291) | 124 |
| Noncurrent liabilities | (266) | (123) | (809) |
| Other | (674) | (1,087) | 237 |
| Net Cash Provided by Operating Activities | 10,922 | 6,451 | 10,376 |
| Cash Flows from Investing Activities | |||
| Capital expenditures | (2,615) | (1,888) | (1,614) |
| Purchases of securities and other investments | (7,994) | (10,739) | (15,651) |
| Proceeds from sales of securities and other investments | 15,252 | 15,664 | 14,353 |
| Acquisitions, net of cash acquired | (431) | (396) | (780) |
| Other | 102 | 38 | 482 |
| Net Cash Provided by (Used in) Investing Activities | 4,314 | 2,679 | (3,210) |
| Cash Flows from Financing Activities | |||
| Net change in short-term borrowings | 5,124 | (26) | 0 |
| Payments on debt | (4,287) | (1,103) | (2,386) |
| Proceeds from issuance of debt | 0 | 0 | 1,079 |
| Purchases of treasury stock | (9,091) | (4,014) | (3,434) |
| Dividends paid to stockholders | (5,172) | (5,167) | (5,124) |
| Proceeds from exercise of stock options | 591 | 499 | 939 |
| Other | (325) | (195) | (118) |
| Net Cash Used in Financing Activities | (13,160) | (10,006) | (9,044) |
| Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash | (205) | 457 | (131) |
| Net Increase (Decrease) in Cash, Cash Equivalents and Restricted Cash | 1,871 | (419) | (2,009) |
| Cash, Cash Equivalents and Restricted Cash at Beginning of Year (includes $4 million of restricted cash at January 1, 2018 included in Other Assets) | 6,096 | 6,515 | |
| Cash, Cash Equivalents and Restricted Cash at End of Year (includes $2 million of restricted cash at December 31, 2018 included in Other Assets) | 7,967 | 6,096 | 6,515 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
MERCK & CO., INC. | ||
Ticker: MRK Fiscal Year: 2018 | ||
Consolidated Balance Sheet | ||
Period Ending Dec 31, 2018 10-K (Filed: Feb 27, 2019) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2018 | Dec 31, 2017 | |
| Assets | ||
| Current Assets | ||
| Cash and cash equivalents | $ 7,965 | 6,092 |
| Short-term investments | 899 | 2,406 |
| Accounts receivable (net of allowance for doubtful accounts of $119 in 2018 and $159 in 2017) | 7,071 | 6,873 |
| Inventories (excludes inventories of $1,417 in 2018 and $1,187 in 2017 classified in Other assets - see Note 7) | 5,440 | 5,096 |
| Other current assets | 4,500 | 4,299 |
| Total current assets | 25,875 | 24,766 |
| Investments | 6,233 | 12,125 |
| Property, Plant and Equipment (at cost) | ||
| Land | 333 | 365 |
| Buildings | 11,486 | 11,726 |
| Machinery, equipment and office furnishings | 14,441 | 14,649 |
| Construction in progress | 3,355 | 2,301 |
| Property, plant and equipment (at cost) | 29,615 | 29,041 |
| Less: accumulated depreciation | 16,324 | 16,602 |
| Property, plant and equipment, net | 13,291 | 12,439 |
| Goodwill | 18,253 | 18,284 |
| Other Intangibles, Net | 11,431 | 14,183 |
| Other Assets | 7,554 | 6,075 |
| Total Assets | 82,637 | 87,872 |
| Liabilities and Equity | ||
| Current Liabilities | ||
| Loans payable and current portion of long-term debt | 5,308 | 3,057 |
| Trade accounts payable | 3,318 | 3,102 |
| Accrued and other current liabilities | 10,151 | 10,427 |
| Income taxes payable | 1,971 | 708 |
| Dividends payable | 1,458 | 1,320 |
| Total current liabilities | 22,206 | 18,614 |
| Long-Term Debt | 19,806 | 21,353 |
| Deferred Income Taxes | 1,702 | 2,219 |
| Other Noncurrent Liabilities | 12,041 | 11,117 |
| Merck & Co., Inc. Stockholders Equity | ||
| Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2018 and 2017 | 1,788 | 1,788 |
| Other paid-in capital | 38,808 | 39,902 |
| Retained earnings | 42,579 | 41,350 |
| Accumulated other comprehensive loss | (5,545) | (4,910) |
| Stockholders' equity before deduction for treasury stock | 77,630 | 78,130 |
| Less treasury stock, at cost: 984,543,979 shares in 2018 and 880,491,914 shares in 2017 | 50,929 | 43,794 |
| Total Merck & Co., Inc. stockholders equity | 26,701 | 34,336 |
| Noncontrolling Interests | 181 | 233 |
| Total equity | 26,882 | 34,569 |
| Total Liabilities and Equity | 82,637 | 87,872 |
| External Links | |
| MERCK & CO., INC. (MRK) Fiscal Year 2018 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |